Culture Biosciences develops automated bio-reactors that helps companies optimize their manufacturing processes. Founded by Matthew Ball and Will Patrick in 2016, Culture Biosciences is backed by investors that include Y Combinator, UpHonest Capital, Verily, MIT Media Lab, and Section 32 and is headquartered in San Francisco.